FMC - Bruceton Mills is a medicare approved dialysis facility center in Bruceton Mills, West Virginia and it has 16 dialysis stations. It is located in Preston county at 856 Casteel Road, Bruceton Mills, WV, 26525. You can reach out to the office of FMC - Bruceton Mills at (304) 379-2770. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Bruceton Mills has the following ownership type - Profit. It was first certified by medicare in October, 2006. The medicare id for this facility is 512527 and it accepts patients under medicare ESRD program.
| Name | FMC - Bruceton Mills |
|---|---|
| Location | 856 Casteel Road, Bruceton Mills, West Virginia |
| No. of Dialysis Stations | 16 |
| Medicare ID | 512527 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 856 Casteel Road, Bruceton Mills, West Virginia, 26525 | |
| (304) 379-2770 | |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
| NPI Number | 1669430484 |
| Organization Name | Fresenius Medical Care Of Bruceton Mills |
| Doing Business As | Bio-medical Applications Of West Virginia Inc. |
| Address | 856 Casteel Rd Bruceton Mills, West Virginia, 26525 |
| Phone Number | (304) 379-2770 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
| Dialysis patients with Hemoglobin data | 7 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 25 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 175 |
| Percentage of adult patients getting regular hemodialysis at the center | 96 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
| Adult patients getting regular peritoneal dialysis at the center | 7 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 47 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Bruceton Mills with elevated calcium levels.
| Patients with hypercalcemia | 30 |
| Hypercalcemia patient months | 224 |
| Patients with Serumphosphor | 32 |
| Patients with Serumphosphor less than 3.5 mg/dL | 6 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 23 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 37 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 23 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 21 |
| Patient months included in arterial venous fistula and catheter summaries | 119 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 61 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 13 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 26 |
| Hospitalization Rate in facility | 305.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 593.7 |
| Hospitalization Rate: Lower Confidence Limit | 165.3 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC - Bruceton Mills were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 22.7 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 36 |
| Readmission Rate: Lower Confidence Limit | 12.4 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC - Bruceton Mills get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .88 (As Expected) |
| SIR: Upper Confidence Limit | 2.91 |
| SIR: Lower Confidence Limit | .15 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC - Bruceton Mills's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 24 |
| Transfusion Rate in facility | 137.6 (Worse than Expected) |
| Transfusion Rate: Upper Confidence Limit | 353.8 |
| Transfusion Rate: Lower Confidence Limit | 60.1 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
The rate of mortality show you whether patients who were being treated regularly at FMC - Bruceton Mills lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 119 |
| Mortality Rate in facility | 13 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 21.7 |
| Mortality Rate: Lower Confidence Limit | 7.1 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago
FMC - Bruceton Mills Location: 856 Casteel Road, Bruceton Mills, West Virginia, 26525 Phone: (304) 379-2770 |
News Archive
This month USAA and LTCFP are presenting a free 45-minute seminar that highlights the critical need for long-term care insurance and presents the various public and private financing options that are available. It will be held at multiple times in 4 Ohio cities. The general public, including military personnel, are invited to attend.
Jeffrey D. Zients, a multimillionaire entrepreneur and management consultant, joined the Obama White House in 2009 with a mandate to streamline the federal bureaucracy. A year later, he issued a prescient warning. The government "largely has missed out" on the information technology revolution, Mr. Zients said in a 2010 internal memo. "I.T. projects too often cost hundreds of millions of dollars more than they should, take years longer than necessary to deploy and deliver technologies that are obsolete by the time they are completed," he wrote. These days, Mr. Zients is witnessing that ineptitude up close as the emergency fix-it man charged with righting HealthCare.gov (Stolberg, 11/10).
Treating multidrug-resistant tuberculosis (MDR TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this week in PLOS Medicine.
Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.
› Verified 9 days ago